Idiopathic myelofibrosis: a clinical study of 80 patients.
about
MPNs as Inflammatory Diseases: The Evidence, Consequences, and PerspectivesThe Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsA 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisImmune thrombocytopenia in postpolythemic myelofibrosis.Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα.Myelodysplastic syndrome associated with bone marrow fibrosis.Development of acute leukaemia after idiopathic myelofibrosis.Osteomyelosclerosis with thalassemia trait: report of a rare association, study of platelet function tests and review of literature.Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes.Perspectives on the impact of JAK-inhibitor therapy upon inflammation-mediated comorbidities in myelofibrosis and related neoplasms.An immune dysregulation in MPN.MDS and GCA: a prognostic dilemma.Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms.Extrahepatic manifestations of hepatitis B virus infection: Addison's disease and myelofibrosis in a patient with persistent hepatitis B surface antigenemia.Carotid Artery Stiffness, Digital Endothelial Function, and Coronary Calcium in Patients with Essential Thrombocytosis, Free of Overt Atherosclerotic Disease.Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis.Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review.
P2860
Q26775996-00A9FA64-D35A-43A3-9705-0C5DE28E7947Q26779929-097368B8-5661-4784-81B9-B30570A84DC0Q28553797-1C77E0CF-709E-40C2-BAFF-C95950D45DC4Q33498469-4998EE87-C735-4B15-A8BF-3B62BAAA02FEQ35203067-D77DCBFD-7686-44FB-B005-74D30EB1B1D2Q35664744-D28F985A-7CBD-410A-A3C4-190730AFED58Q37111638-9A6092B4-A017-4FB9-9653-31966E2FB5C3Q37212358-E7F21841-0391-485C-97A7-CEF5C26B5248Q37548944-F8380503-C46B-4FB8-8A5F-D81ED0E7973FQ38187674-C45DF2DE-4D29-4120-B8F4-D32333F52A37Q38241495-D8906E96-FAB1-42BC-81FE-2530EE3A47FEQ38529556-052ED494-0EA5-48B1-8C16-8AB4265F7073Q39722432-453A244C-77EB-49D8-993D-652B539BFA73Q40141678-4F1FBAD5-CCF8-412A-AC72-A5AC3B46B242Q40489397-A3A492DC-8AA4-4A4D-8A9B-3B0EA2D2C163Q44667229-8E76C0B6-18AE-4CCF-95D6-04126969D010Q51008176-EBA26548-AE7D-4BA4-BDE9-B458D6A49E45Q53111428-7213CC64-BE65-4253-9BFD-85E3E3C8247E
P2860
Idiopathic myelofibrosis: a clinical study of 80 patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Idiopathic myelofibrosis: a clinical study of 80 patients.
@en
Idiopathic myelofibrosis: a clinical study of 80 patients.
@nl
type
label
Idiopathic myelofibrosis: a clinical study of 80 patients.
@en
Idiopathic myelofibrosis: a clinical study of 80 patients.
@nl
prefLabel
Idiopathic myelofibrosis: a clinical study of 80 patients.
@en
Idiopathic myelofibrosis: a clinical study of 80 patients.
@nl
P2860
P356
P1476
Idiopathic myelofibrosis: a clinical study of 80 patients.
@en
P2093
Hasselbalch H
P2860
P304
P356
10.1002/AJH.2830340411
P577
1990-08-01T00:00:00Z